SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA

Amanda Jack(University of California, Berkeley), Luke S. Ferro(University of California, Berkeley), Michael J. Trnka(University of California, San Francisco), Eddie Wehri(University of California, Berkeley), Amrut Nadgir(University of California, Berkeley), Xammy Huu Wrynla(University of California, Berkeley), Douglas Fox(University of California, Berkeley), Katelyn Costa, Sarah A. Stanley(University of California, Berkeley), Julia Schaletzky(University of California, Berkeley), Ahmet Yıldız(University of California, Berkeley)
PLoS Biology
October 11, 2021
Cited by 169Open Access
Full Text

Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection causes Coronavirus Disease 2019 (COVID-19), a pandemic that seriously threatens global health. SARS-CoV-2 propagates by packaging its RNA genome into membrane enclosures in host cells. The packaging of the viral genome into the nascent virion is mediated by the nucleocapsid (N) protein, but the underlying mechanism remains unclear. Here, we show that the N protein forms biomolecular condensates with viral genomic RNA both in vitro and in mammalian cells. While the N protein forms spherical assemblies with homopolymeric RNA substrates that do not form base pairing interactions, it forms asymmetric condensates with viral RNA strands. Cross-linking mass spectrometry (CLMS) identified a region that drives interactions between N proteins in condensates, and deletion of this region disrupts phase separation. We also identified small molecules that alter the size and shape of N protein condensates and inhibit the proliferation of SARS-CoV-2 in infected cells. These results suggest that the N protein may utilize biomolecular condensation to package the SARS-CoV-2 RNA genome into a viral particle.


Related Papers

No related papers found

Powered by citation graph analysis